These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7918079)

  • 1. Additive in vitro effects of anti-sickling drugs.
    Stuart J; Mojiminiyi FB; Stone PC; Culliford SJ; Ellory JC
    Br J Haematol; 1994 Apr; 86(4):820-3. PubMed ID: 7918079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted benzaldehydes (12C79 and 589C80) that stabilize oxyhaemoglobin also protect sickle cells against calcium-mediated dehydration.
    Stone PC; Nash GB; Stuart J
    Br J Haematol; 1992 Jul; 81(3):419-23. PubMed ID: 1390217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.
    Brugnara C; Gee B; Armsby CC; Kurth S; Sakamoto M; Rifai N; Alper SL; Platt OS
    J Clin Invest; 1996 Mar; 97(5):1227-34. PubMed ID: 8636434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.
    Brugnara C; de Franceschi L; Alper SL
    J Clin Invest; 1993 Jul; 92(1):520-6. PubMed ID: 8326017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the mechanical properties of sickle cells by repetitive deoxygenation: role of calcium and the effects of calcium blockers.
    Nash GB; Boghossian S; Parmar J; Dormandy JA; Bevan D
    Br J Haematol; 1989 Jun; 72(2):260-4. PubMed ID: 2757968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bepridil protects sickle cells against the adverse rheological effects of cyclical deoxygenation.
    Johnston MN; Ellory JC; Stuart J
    Br J Haematol; 1989 Dec; 73(4):522-6. PubMed ID: 2611138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease.
    Keidan AJ; Sowter MC; Johnson CS; Marwah SS; Stuart J
    Clin Sci (Lond); 1989 Apr; 76(4):357-62. PubMed ID: 2714049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action and comparative efficacy of pharmacological agents that inhibit calcium-dependent dehydration of sickle cells.
    Ellory JC; Nash GB; Stone PC; Culliford SJ; Horwitz E; Stuart J
    Br J Pharmacol; 1992 Aug; 106(4):972-7. PubMed ID: 1393295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine and clotrimazole inhibit sickle erythrocyte dehydration induced by 1-chloro-2,4-dinitrobenzene.
    Shartava A; Shah AK; Goodman SR
    Am J Hematol; 1999 Sep; 62(1):19-24. PubMed ID: 10467272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
    Stuart J; Stone PC; Bilto YY; Keidan AJ
    J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydration response of sickle cells to sickling-induced Ca(++) permeabilization.
    Lew VL; Etzion Z; Bookchin RM
    Blood; 2002 Apr; 99(7):2578-85. PubMed ID: 11895796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipyridamole inhibits sickling-induced cation fluxes in sickle red blood cells.
    Joiner CH; Jiang M; Claussen WJ; Roszell NJ; Yasin Z; Franco RS
    Blood; 2001 Jun; 97(12):3976-83. PubMed ID: 11389043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the antisickling compound GBT1118 on the permeability of red blood cells from patients with sickle cell anemia.
    Al Balushi H; Dufu K; Rees DC; Brewin JN; Hannemann A; Oksenberg D; Lu DC; Gibson JS
    Physiol Rep; 2019 Mar; 7(6):e14027. PubMed ID: 30916477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
    de Franceschi L; Rouyer-Fessard P; Alper SL; Jouault H; Brugnara C; Beuzard Y
    Blood; 1996 Feb; 87(3):1188-95. PubMed ID: 8562946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bepridil as an antisickling agent: membrane internalization and cell rigidity.
    Johnson RM; Acquaye C; Féo C; Sarnaik S
    Am J Hematol; 1994 Aug; 46(4):310-8. PubMed ID: 8037182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells.
    Benton DC; Roxburgh CJ; Ganellin CR; Shiner MA; Jenkinson DH
    Br J Pharmacol; 1999 Jan; 126(1):169-78. PubMed ID: 10051133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-hydroxymethyl-2-furfural on the volume and membrane permeability of red blood cells from patients with sickle cell disease.
    Hannemann A; Cytlak UM; Rees DC; Tewari S; Gibson JS
    J Physiol; 2014 Sep; 592(18):4039-49. PubMed ID: 25015917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of deformability (filterability) of sickle cells by BW12C during progressive deoxygenation.
    Kenny MW; Stuart J
    Br J Haematol; 1983 Nov; 55(3):465-71. PubMed ID: 6639888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.
    Stocker JW; De Franceschi L; McNaughton-Smith GA; Corrocher R; Beuzard Y; Brugnara C
    Blood; 2003 Mar; 101(6):2412-8. PubMed ID: 12433690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.